Skip to main content
Premium Trial:

Request an Annual Quote

Fred Hutchinson, NSB Partner on Protein Microarray Research

NEW YORK (GenomeWeb News) – Fred Hutchinson Cancer Research Center yesterday announced that it is collaborating with South Korea-based NSB Postech on research into protein microarrays.
 
The partners are coordinating efforts to determine the efficacy of NSB’s NanoCones surface technology in creating proteomic microarrays to be used in studying human diseases, the Hutchinson Center said. The collaboration will include a comparison of slides created with NSB’s technology with current industry standard technology.
 
“We hope this will make our antibody arrays more sensitive and accurate,” Paul Lampe, a member of the Hutchinson Center’s Public Health Sciences Division and associate program head of molecular diagnostics, said in a statement.
 
NSB will fund the collaboration. Further terms of the alliance were not disclosed.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.